Mycophenolate mofetil treatment for IgA nephropathy: A meta-analysis

American Journal of Nephrology

Volumn 29, Issue 5, 2009, Pages 362-367

  Xu, Gaosi ^a,b   Tu, Weiping ^a   Jiang, Dongfeng ^b   Xu, Chengyun ^a  

^a NANCHANG UNIVERSITY   (China)

^b JIANGXI MEDICAL COLLEGE   (China)

Author keywords

Immunoglobulin A nephropathy; Meta analysis; Mycophenolate mofetil

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; STEROID;

CLINICAL TRIAL; COCHRANE LIBRARY; DIARRHEA; GASTRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION;

CREATININE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY;

EID: 54949123838     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000168483     Document Type: Review

References (21)

1. Adu D, Cross J, Jayne DR: Treatment of systemic lupus erythematosus with mycophe-nolate mofetil. Lupus 2001; 10:203-208.
2. Eropean Mycophenolate Mofetil Cooperative Study Group: Placebo controlled study of mycophenolate mofetil combined with cy-closporin and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321-1325.
3. Sahin GM, Sahin S, Kantarci G, Ergin H: Mycophenolate mofetil treatment for therapy-resistant glomerulopathies. Nephrology (Carlton) 2007;12:285-288.
4. Bergner R, Hoffmann M, Brass H, Uppenkamp M: Therapy of IgA nephropathy with mycophenolate mofetil: report of 3 cases. Clin Nephrol 2004;61:207-212.
5. Chen X, Chen P, Cai G, Wu J, Cui Y, Zhang Y, Liu S, Tang L: A randomized control trial of mycophenolate mofetil treatment in severe IgA nephropathy (in Chinese). Zhonghua Yi Xue Za Zhi 2002;82:796-801.
6. Tang S, Leung JCK, Chan LYY, Lui YH, Tang CSO, Kan CH, Ho YW, Lai KN: Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 2005;68: 802-812.
7. Maes BD, Oyen R, Claes K, Evenepoel P, Kuypers D, Vanwalleghem J, Van Damme B, Vanrenterghem YFC: Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 2004;65:1842-1849.
8. Frisch G, Lin J, Rosenstock J, Markowitz G, D'Agati V, Radhakrishnan J, Preddie D, Grew J, Valeri A, Appel G: Mycophenolate mofetil (MMF) vs. placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant 2005;20:2139-2145.
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
10. Levy M, Berger J: Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-347.
11. Velo M, Lozano L, Egido J, Gutierrez-Milet V, Hernando L: Natural history of IgA nephropathy followed up for more than 10 years in Spain. Semin Nephrol 1987;7:346-350.
12. Radford MG, Donadio JV Jr, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997;8:199-207.
13. Van der Woude FJ: Mycophenolate mofetil (RS 61443): nothing new under the sun or an important break-through in the field of transplantation? Nephrol Dial Transplant 1995;10:1112-1115.
14. Dubus I, Vendrely B, Christophe I, Labouyrie JP, Delmas Y, Bonnet J, Combe C: Myco-phenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int 2002;62:857-867.
15. Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M: Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 1999; 14:58-63.
16. Yu CC, Yang CW, Wu MS, Ko YC, Huang CT, Hong JJ, Huang CC: Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice. J Lab Clin Med 2001; 138:69-77.
17. Nowack R, Birck R, van der Woude FJ: Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1997;349:774.
18. Briggs WA, Choi MJ, Scheel PJ Jr: Successful mycophenolate mofetil treatment of glomer-ular disease. Am J Kidney Dis 1998;31:213-217.
19. Ioannidis JP: Genetic associations: false or true? Trends Mol Med 2003;9:135-138.
20. Lee YH, Harley JB, Nath SK: CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis. Hum Genet 2005; 116:361-367.
21. Hogg RJ, Wyatt RJ: Scientific Planning Committee of the North American IgA Nephropathy Study: a randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]. BMC Nephrol 2004;5:3.